Toggle navigation
News
Blog
About Us
Contact Us
Type 2 diabetes remission: Reducing excess fat in the liver might be the keyteaser
Unleashing the Truth: How to Put T2D Patients’ Hearts First
Cardiologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
Mechanisms of Action of GLP-1 Agonists in T2D
Top health insurer to launch a program for controlling T2D
PILA PHARMA
EASD 2019 : Personalised Prevention Of CVD In T2D- Prof Alessandro Doria
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Unleashing the Truth: Approaching T2D Treatment as a Team Sport
Unleashing the Truth: How to Put T2D Patients’ Hearts First
Type 2 Diabetes: Dr Stephen Hull – Practical Advice for People with T2D and Heart Disease
4 simple tips to reverse Type 2 Diabetes
Diabetes debunked: Fact vs. fiction on ways to prevent, manage, and reverse the disease
[Preview] A low-carb diet for T2D reversal – Dr. Sarah Hallberg
Introduction to SGLT2 Inhibition
Type 2 Diabetes and Cardiovascular Disease: Risk Factors
Reversing T2D with a keto diet — Diet Doctor Podcast with Dr. Sarah Hallberg
Medication adherence in Malaysian patients with T2D – Video abstract 81612
Low carb for diabetes: A transformation — Diet Doctor Podcast
Hua Medicine – A Global Effort to Stop Diabetes
Rogelio Braceras, MD: Improving Costs, Comorbidities in T2D
Sodium-Glucose Transporter-2 Inhibition: An Important Advancement for Patients with T2D and CKD
Team-based care for patients with T2D and kidney disease | Katherine R Tuttle & Jay H Shubrook
GLP-1 Agonist Therapy in a Patient With T2D and CVD
Type 2 Diabetes: Dr Hull – The Focus of Treatment in T2D
T2D and CV Risk Reduction: Future Management
A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity
Don’t manage type 2 diabetes, reverse it!
Diabetologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients
The Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Zanetti et al; Birthweight, T2D, and Cardiovascular Disease
Diabetes Epigenome Atlas (DGA) and T2D Knowledge Portal: September 26, 2019 Webinar
Dr. David Unwin – ‘The Glycaemic Index: Helping Patients in Primary care with T2D’
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
News
A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity
The Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Don’t manage type 2 diabetes, reverse it!
PILA PHARMA
Diabetes debunked: Fact vs. fiction on ways to prevent, manage, and reverse the disease
Low carb for diabetes: A transformation — Diet Doctor Podcast
News
Top health insurer to launch a program for controlling T2D
Sodium-Glucose Transporter-2 Inhibition: An Important Advancement for Patients with T2D and CKD
Type 2 Diabetes: Dr Hull – The Focus of Treatment in T2D
Type 2 Diabetes: Dr Stephen Hull – Practical Advice for People with T2D and Heart Disease
T2DTV
Date
Title
Views
Likes
Comments
Order by
Date
Title
Views
Likes
Comments
Wellness Guide
Search for:
New Videos
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity
The Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes
Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes
Don’t manage type 2 diabetes, reverse it!
PILA PHARMA
Diabetes debunked: Fact vs. fiction on ways to prevent, manage, and reverse the disease
Low carb for diabetes: A transformation — Diet Doctor Podcast
Top health insurer to launch a program for controlling T2D
Sodium-Glucose Transporter-2 Inhibition: An Important Advancement for Patients with T2D and CKD
Close
News
Blog
About Us
Contact Us
